ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 230 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $285 | -27.5% | 42,435 | -4.7% | 0.00% | 0.0% |
| Q1 2023 | $393 | -82.4% | 44,517 | -84.8% | 0.00% | -83.3% |
| Q4 2022 | $2,236 | -99.9% | 292,743 | +1.5% | 0.01% | 0.0% |
| Q3 2022 | $2,054,000 | -7.6% | 288,547 | +5.0% | 0.01% | 0.0% |
| Q2 2022 | $2,222,000 | -45.4% | 274,760 | -6.2% | 0.01% | -25.0% |
| Q1 2022 | $4,067,000 | -75.3% | 292,956 | -50.2% | 0.01% | -75.0% |
| Q4 2021 | $16,493,000 | -13.9% | 587,770 | +4.4% | 0.03% | -17.9% |
| Q3 2021 | $19,145,000 | -14.7% | 563,262 | +2.6% | 0.04% | -15.2% |
| Q2 2021 | $22,439,000 | +27.2% | 549,176 | +25.3% | 0.05% | +17.9% |
| Q1 2021 | $17,638,000 | +3629.0% | 438,125 | +5371.1% | 0.04% | +3800.0% |
| Q4 2020 | $473,000 | – | 8,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
| BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
| Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
| Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
| Triatomic Management LP | 121,166 | $813,024 | 0.83% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
| Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
| Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
| ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
| Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |